Nand Wadhwa is a Nephrology physician affiliated with Stony Brook Medicine. OpenAlex indexes 87 publications with 1,588 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
26 Research Way
East Setauket, NY 11733
Telephone
631-444-0580Registry record last updated 8 Jul 2007.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Fresenius USA Manufacturing, Inc.Program year20252 payments
- Travere Therapeutics, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
57%Loop diuretic12.4%Furosemide75%Torsemide25%Part D≥46 patientsAldosterone antagonist (MRA)8.4%Spironolactone85%Eplerenone15%Part D<11 patients+ 12 more classes in this area
Musculoskeletal
21.6%Xanthine oxidase inhibitor21.6%Allopurinol95%Febuxostat5%Part D<11 patientsMetabolism & gastrointestinal
14.7%SGLT2 inhibitor9.7%Farxiga85%Jardiance15%Part D<11 patientsProvitamin D2 Compound1.8%Vitamin D2100%Part D≥12 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Combined aquaretic and diuretic therapy in acute heart failure
International Journal of Nephrology and Renovascular Disease
2017 - Magnesium and Muscle Cramps in End Stage Renal Disease Patients on Chronic Hemodialysis
Advances in Nephrology
2014 - Pet-Related Peritonitis and its Prevention in Peritoneal Dialysis: A Case Study
Peritoneal Dialysis International
2014 - Arteriojejunal Fistula Presenting with Recurrent Obscure GI Hemorrhage in a Patient with a Failed Pancreas Allograft
Case Reports in Transplantation
2013 - Does Current Nephrology Fellowship Training Affect Uti-lization of Peritoneal Dialysis in the United States?
Open Journal of Nephrology
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Gerald Smaldone, MD, PhD
Stony Brook Medicine
Eric Rashba, MD
Stony Brook Medicine
Steven Weissbart
Stony Brook Medicine
Sonya Marcus, MD
Stony Brook Medicine
Andrew Levey, MD
Tufts Medical Center
Glenn M. Chertow
FIND
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”